Cadre Holdings Inc

Análisis de la acción Cadre Holdings Inc (CDRE)

$28.450

-1.161 (-4.08%)Al cierre

Loading chart…
High
30.180
Open
29.370
VWAP
28.91
Vol
367.94K
Mkt Cap
1.34B
Low
28.100
Amount
10.64M
EV/EBITDA, TTM
13.33

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

AI analysis of Cadre Holdings Inc (CDRE)

hold

Cadre Holdings Inc is currently not a strong buy due to recent insider selling and declining stock performance, despite analysts projecting a price target of $43, which suggests a potential upside of 40% from the current price of $30.74. The RSI is at 25, indicating the stock is oversold, but the recent 9.91% drop over the last 5 days raises concerns. The main risk is the CEO's recent sale of 75,000 shares, which may signal a lack of confidence in the company's future performance.

Métricas de valoración

The current forward P/E ratio for Cadre Holdings Inc (CDRE) is 24.10, compared to its 5-year average forward P/E of 30.58.

Forward P/E

Fair
5Y Average P/E
30.58
Current P/E
24.10
Sobrevalorada
46.68
Infravalorada
14.48

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
13.25
Current EV/EBITDA
13.33
Sobrevalorada
15.10
Infravalorada
11.41

Forward P/S

Undervalued
5Y Average P/S
2.02
Current P/S
1.63
Sobrevalorada
2.34
Infravalorada
1.70

Alphio AI Price Scenarios for CDRE

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CDRE

$34.59

Precio del escenario

B

Base

Base · 50%CDRE

$30.16

Precio del escenario

B

Bear

Bear · 25%CDRE

$29.75

Precio del escenario

Whales holding CDRE

G

Greenhouse Funds LLLP

+ HoldingCDRE

+10.78%

3M Return

R

Reinhart Partners, LLC

+ HoldingCDRE

-3.87%

3M Return

Cronología de eventos

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

Noticias

CDRE FAQ — answered by Alphio AI

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is currently not a strong buy due to recent insider selling and declining stock performance, despite analysts projecting a price target of $43, which suggests a potential upside of 40% from the current price of $30.74. The RSI is at 25, indicating the stock is oversold, but the recent 9.91% drop over the last 5 days raises concerns. The main risk is the CEO's recent sale of 75,000 shares, which may signal a lack of confidence in the company's future performance.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis